Matches in Wikidata for { <http://www.wikidata.org/entity/Q92961563> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q92961563 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92961563 description "scientific article published on 29 August 2019" @default.
- Q92961563 description "wetenschappelijk artikel" @default.
- Q92961563 description "наукова стаття, опублікована 29 серпня 2019" @default.
- Q92961563 name "The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy" @default.
- Q92961563 name "The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy" @default.
- Q92961563 type Item @default.
- Q92961563 label "The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy" @default.
- Q92961563 label "The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy" @default.
- Q92961563 prefLabel "The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy" @default.
- Q92961563 prefLabel "The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy" @default.
- Q92961563 P1433 Q92961563-02CB734E-9ACC-4B25-B280-B896461201DF @default.
- Q92961563 P1476 Q92961563-8BD080A4-CE0A-46CA-A9A5-BDBA19941EA3 @default.
- Q92961563 P2093 Q92961563-0B7085CB-09AA-446F-A9F9-67BD7D6241B9 @default.
- Q92961563 P2093 Q92961563-E41F8A7F-3288-4C3F-AC3F-4E091906B208 @default.
- Q92961563 P304 Q92961563-221E10B9-0837-41C0-A61C-9B05CC559576 @default.
- Q92961563 P31 Q92961563-DD410CD3-DE99-407B-ABAA-F59A635267D3 @default.
- Q92961563 P356 Q92961563-2B4910B0-B7F7-4832-A4A2-F07927BA2902 @default.
- Q92961563 P50 Q92961563-109E4BBF-49FE-4916-8864-F39EB34FC93B @default.
- Q92961563 P50 Q92961563-168D13F8-9C05-4218-A98C-DBC0E2CFDC11 @default.
- Q92961563 P50 Q92961563-22FFCB2F-DCBC-4E2A-A848-24873BB92ABE @default.
- Q92961563 P50 Q92961563-2A60ADDF-3063-4AC3-A7FF-D810FC35061B @default.
- Q92961563 P50 Q92961563-54548190-3700-4863-BB0D-C9C27308A6BB @default.
- Q92961563 P50 Q92961563-7AB2953F-91D7-4C78-B104-E81549CE34C5 @default.
- Q92961563 P50 Q92961563-CB5D7411-013C-4F2C-9082-844EA877A710 @default.
- Q92961563 P577 Q92961563-70E33ECA-3DC3-4C5B-ACEC-71F9D6036EB5 @default.
- Q92961563 P698 Q92961563-6838CD50-02D8-46B9-81EE-3D5A9B5311E8 @default.
- Q92961563 P356 0284186X.2019.1656342 @default.
- Q92961563 P698 31462137 @default.
- Q92961563 P1433 Q326164 @default.
- Q92961563 P1476 "The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy" @default.
- Q92961563 P2093 "H Malcolm Hudson" @default.
- Q92961563 P2093 "Val Gebski" @default.
- Q92961563 P304 "1-8" @default.
- Q92961563 P31 Q13442814 @default.
- Q92961563 P356 "10.1080/0284186X.2019.1656342" @default.
- Q92961563 P50 Q42721742 @default.
- Q92961563 P50 Q45637596 @default.
- Q92961563 P50 Q54276589 @default.
- Q92961563 P50 Q67471179 @default.
- Q92961563 P50 Q89841525 @default.
- Q92961563 P50 Q91746697 @default.
- Q92961563 P50 Q92961559 @default.
- Q92961563 P577 "2019-08-29T00:00:00Z" @default.
- Q92961563 P698 "31462137" @default.